iECURE Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of ECUR-506 Ahead of Planned BLA Submission

Go back to iECURE Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of ECUR-506 Ahead of Planned BLA Submission
(NASDAQ: DTIL) Delayed: 7.88 +0.02 (0.25%)
Previous Close $7.86    52 Week High
Open $7.96    52 Week Low
Day High $8.10    P/E N/A 
Day Low $7.55    EPS
Volume 446,050